Progestin-containing Intrauterine System class drugs

8 results

  • Balcoltra

    (levonorgestrel and ethinyl estradiol)
    Avion Pharmaceuticals
    Usage: Balcoltra is indicated for females of reproductive potential for the prevention of pregnancy.

  • Climara pro

    (Estradiol and Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.

  • Kyleena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.

  • Liletta

    (Levonorgestrel)
    Allergan, Inc.
    Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.

  • Mirena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.

  • Skyla

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Skyla® is indicated for the prevention of pregnancy for up to 3 years. If continued use is desired, the system should be replaced after this duration.

  • Twirla

    (levonorgestrel/ethinyl estradiol)
    Agile Therapeutics, Inc.
    Usage: TWIRLA is indicated for contraception in women of reproductive potential with a BMI < 30 kg/m². However, caution is advised for those with a BMI ≥ 25 to < 30 kg/m² due to reduced effectiveness, and it is contraindicated for women with a BMI ≥ 30 kg/m².

  • Tyblume

    (Levonorgestrel and Ethinyl Estradiol)
    Exeltis USA, Inc.
    Usage: TYBLUME is indicated for females of reproductive potential to prevent pregnancy.